retatrutide the same as mounjaro (“reta”) is an experimental weight-loss drug currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. reason comes down to how it works Retatrutide vs Mounjaro: The Future

Our studies revealed key signaling mechanisms underlying the role of GPR17 in regulating GLP-1 secretion and suggest future opportunities for pharmacologically targeting GPR17 with inverse agonists to maximize GLP-1 secretion ![Graphical Abstract][1] Graphical Abstract ### Competing Interest Statement The authors have declared no competing interest

phosphorus: 20% of the DV

But another conversation has begun gaining momentum centered on fiber and the gut microbiome.

Researchers and leading pharma scientists now ask: could GLP-1s be our first true longevity drugs

GLP-1 S is a GLP-1 receptor agonist the same class behind today's leading weight-management research studied for appetite control, blood-sugar